Clinical outcome in pleomorphic lobular carcinoma: A case-control study with comparison to classic invasive lobular carcinoma

Sonia Narendra, Sarah M. Jenkins, Andras Khoor, Aziza Nassar

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Abstract Pleomorphic lobular carcinoma (PLC), a variant of invasive lobular carcinoma (ILC) is described as an aggressive tumor with poor prognosis. Multiple studies show lower overall survival for patients with PLC than for patients with classic ILC (cILC). We compared the clinicopathologic characteristics of PLC with those of cILC. All cases with a diagnosis of ILC, Nottingham grades 2 or 3 that were diagnosed between January 1, 1990, and December 31, 2010, were retrieved from pathology files in the institutional anatomic pathology database. The cases (N = 52) were reviewed to identify those meeting the criteria for PLC. An E-cadherin immunostain was used to confirm the lobular immunophenotype. Clinicopathologic data were assessed and analyzed. A control group (N = 103) of cILC, Nottingham grade 1, was selected, with 2 controls for each case, matched by age and year of diagnosis. PLC was associated more closely with in situ carcinoma (P =.03), and had lower progesterone receptor expression (P =.03) than cILC. Both disease-free survival and overall survival were similar between patients with PLC and matched cILC controls, and both depended on disease stage, tumor size, and lymph node status. PLC is similar to cILC in terms of patient survival and outcomes.

Original languageEnglish (US)
Article number50969
Pages (from-to)64-69
Number of pages6
JournalAnnals of Diagnostic Pathology
Volume19
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Lobular Carcinoma
Case-Control Studies
Survival
Pathology
Carcinoma in Situ
Progesterone Receptors
Cadherins
Disease-Free Survival
Neoplasms
Lymph Nodes
Databases

Keywords

  • Classic lobular carcinoma
  • Outcome
  • Pleomorphic lobular carcinoma
  • Survival

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Clinical outcome in pleomorphic lobular carcinoma : A case-control study with comparison to classic invasive lobular carcinoma. / Narendra, Sonia; Jenkins, Sarah M.; Khoor, Andras; Nassar, Aziza.

In: Annals of Diagnostic Pathology, Vol. 19, No. 2, 50969, 01.04.2015, p. 64-69.

Research output: Contribution to journalArticle

@article{7d049869954041d8a3c6e4ee1cb0f241,
title = "Clinical outcome in pleomorphic lobular carcinoma: A case-control study with comparison to classic invasive lobular carcinoma",
abstract = "Abstract Pleomorphic lobular carcinoma (PLC), a variant of invasive lobular carcinoma (ILC) is described as an aggressive tumor with poor prognosis. Multiple studies show lower overall survival for patients with PLC than for patients with classic ILC (cILC). We compared the clinicopathologic characteristics of PLC with those of cILC. All cases with a diagnosis of ILC, Nottingham grades 2 or 3 that were diagnosed between January 1, 1990, and December 31, 2010, were retrieved from pathology files in the institutional anatomic pathology database. The cases (N = 52) were reviewed to identify those meeting the criteria for PLC. An E-cadherin immunostain was used to confirm the lobular immunophenotype. Clinicopathologic data were assessed and analyzed. A control group (N = 103) of cILC, Nottingham grade 1, was selected, with 2 controls for each case, matched by age and year of diagnosis. PLC was associated more closely with in situ carcinoma (P =.03), and had lower progesterone receptor expression (P =.03) than cILC. Both disease-free survival and overall survival were similar between patients with PLC and matched cILC controls, and both depended on disease stage, tumor size, and lymph node status. PLC is similar to cILC in terms of patient survival and outcomes.",
keywords = "Classic lobular carcinoma, Outcome, Pleomorphic lobular carcinoma, Survival",
author = "Sonia Narendra and Jenkins, {Sarah M.} and Andras Khoor and Aziza Nassar",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.anndiagpath.2015.01.005",
language = "English (US)",
volume = "19",
pages = "64--69",
journal = "Annals of Diagnostic Pathology",
issn = "1092-9134",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Clinical outcome in pleomorphic lobular carcinoma

T2 - A case-control study with comparison to classic invasive lobular carcinoma

AU - Narendra, Sonia

AU - Jenkins, Sarah M.

AU - Khoor, Andras

AU - Nassar, Aziza

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Abstract Pleomorphic lobular carcinoma (PLC), a variant of invasive lobular carcinoma (ILC) is described as an aggressive tumor with poor prognosis. Multiple studies show lower overall survival for patients with PLC than for patients with classic ILC (cILC). We compared the clinicopathologic characteristics of PLC with those of cILC. All cases with a diagnosis of ILC, Nottingham grades 2 or 3 that were diagnosed between January 1, 1990, and December 31, 2010, were retrieved from pathology files in the institutional anatomic pathology database. The cases (N = 52) were reviewed to identify those meeting the criteria for PLC. An E-cadherin immunostain was used to confirm the lobular immunophenotype. Clinicopathologic data were assessed and analyzed. A control group (N = 103) of cILC, Nottingham grade 1, was selected, with 2 controls for each case, matched by age and year of diagnosis. PLC was associated more closely with in situ carcinoma (P =.03), and had lower progesterone receptor expression (P =.03) than cILC. Both disease-free survival and overall survival were similar between patients with PLC and matched cILC controls, and both depended on disease stage, tumor size, and lymph node status. PLC is similar to cILC in terms of patient survival and outcomes.

AB - Abstract Pleomorphic lobular carcinoma (PLC), a variant of invasive lobular carcinoma (ILC) is described as an aggressive tumor with poor prognosis. Multiple studies show lower overall survival for patients with PLC than for patients with classic ILC (cILC). We compared the clinicopathologic characteristics of PLC with those of cILC. All cases with a diagnosis of ILC, Nottingham grades 2 or 3 that were diagnosed between January 1, 1990, and December 31, 2010, were retrieved from pathology files in the institutional anatomic pathology database. The cases (N = 52) were reviewed to identify those meeting the criteria for PLC. An E-cadherin immunostain was used to confirm the lobular immunophenotype. Clinicopathologic data were assessed and analyzed. A control group (N = 103) of cILC, Nottingham grade 1, was selected, with 2 controls for each case, matched by age and year of diagnosis. PLC was associated more closely with in situ carcinoma (P =.03), and had lower progesterone receptor expression (P =.03) than cILC. Both disease-free survival and overall survival were similar between patients with PLC and matched cILC controls, and both depended on disease stage, tumor size, and lymph node status. PLC is similar to cILC in terms of patient survival and outcomes.

KW - Classic lobular carcinoma

KW - Outcome

KW - Pleomorphic lobular carcinoma

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84925136848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925136848&partnerID=8YFLogxK

U2 - 10.1016/j.anndiagpath.2015.01.005

DO - 10.1016/j.anndiagpath.2015.01.005

M3 - Article

C2 - 25682191

AN - SCOPUS:84925136848

VL - 19

SP - 64

EP - 69

JO - Annals of Diagnostic Pathology

JF - Annals of Diagnostic Pathology

SN - 1092-9134

IS - 2

M1 - 50969

ER -